Literature DB >> 25341723

Circulating complement levels and C3 glomerulopathy.

Fernando C Fervenza1, Sanjeev Sethi2.   

Abstract

Entities:  

Keywords:  GN; complement; nephritis

Mesh：

Substances：

Year:  2014        PMID： 25341723      PMCID： PMC4220773          DOI： 10.2215/CJN.09620914

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  23 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis.

Authors:  R E Spitzer; A E Stitzel; G C Tsokos
Journal:  Clin Immunol Immunopathol       Date:  1990-10

Review 3.  Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane.

Authors:  Peter F Zipfel; Richard J H Smith; Christine Skerka
Journal:  Nephrol Dial Transplant       Date:  2008-12-04       Impact factor: 5.992

Review 4.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

5.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Authors:  M A Abrera-Abeleda; C Nishimura; J L H Smith; S Sethi; J L McRae; B F Murphy; G Silvestri; C Skerka; M Józsi; P F Zipfel; G S Hageman; R J H Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

6.  Three kidneys, two diseases, one antibody?

Authors:  Nolwenn Lorcy; Nathalie Rioux-Leclercq; Marie-Laure Lombard; Patrick Le Pogamp; Cécile Vigneau
Journal:  Nephrol Dial Transplant       Date:  2011-08-03       Impact factor: 5.992

7.  Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Samih H Nasr; Nelson Leung; Julie Vrana; Carl Cramer; Carla M Nester; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

8.  Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

Authors:  Rubén Martínez-Barricarte; Meike Heurich; Francisco Valdes-Cañedo; Eduardo Vazquez-Martul; Eva Torreira; Tamara Montes; Agustín Tortajada; Sheila Pinto; Margarita Lopez-Trascasa; B Paul Morgan; Oscar Llorca; Claire L Harris; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

9.  Anti-factor B autoantibody in dense deposit disease.

Authors:  Stefanie Strobel; Miriam Zimmering; Krisztián Papp; József Prechl; Mihály Józsi
Journal:  Mol Immunol       Date:  2010-03-01       Impact factor: 4.407

10.  Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).

Authors:  C Licht; S Heinen; M Józsi; I Löschmann; R E Saunders; S J Perkins; R Waldherr; C Skerka; M Kirschfink; B Hoppe; P F Zipfel
Journal:  Kidney Int       Date:  2006-04-12       Impact factor: 10.612
View more
  2 in total

1.  C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction.

Authors:  Ravneet Bajwa; John A DePalma; Taimoor Khan; Anmol Cheema; Sheila A Kalathil; Mohammad A Hossain; Attiya Haroon; Anne Madhurima; Min Zheng; Ali Nayer; Arif Asif
Journal:  Case Rep Nephrol Dial       Date:  2018-02-08

Review 2.  A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease.

Authors:  Francesco Paolo Schena; Pasquale Esposito; Michele Rossini
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.